PADI4 and neoplasm: Indeed, the development of PAD inhibitors has been a progressing area of clinical research for the past decade [73,180,181] and several PAD4-specific inhibitors were reported to have a promising anti-tumour effect in pre-clinical models [37,73,181–186].